AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Danavish Glimepiride+Metformin 2mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Danavish Healthcare

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Danavish Glimepiride+Metformin 2mg/500mg Tablet SR

Glimepiride/Metformin 2mg/500mg extended-release tablets (brand name: Danavish) are classified as antidiabetic medications. This combination therapy treats type 2 diabetes in adults by helping regulate blood sugar. Administer this medication with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood glucose readings. Continuous use is crucial, even with well-controlled blood sugar, as abrupt cessation can lead to elevated glucose, potentially causing kidney damage, vision loss, neuropathy, and limb amputation. Remember, it’s one component of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and trembling. Learn to identify and manage these symptoms. Maintain regular mealtimes and carry a rapid-acting glucose source, such as sugary snacks or juice. Alcohol consumption increases hypoglycemia risk and should be minimized. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Inform your doctor about any history of heart disease before starting treatment, as it may not be appropriate. Pregnant or breastfeeding individuals must consult their physician prior to use. Regular blood sugar monitoring is essential, along with potential blood tests to assess blood cell counts and liver function.

Uses of Danavish Glimepiride+Metformin 2mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Danavish Glimepiride+Metformin 2mg/500mg Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Danavish Glimepiride+Metformin 2mg/500mg Extended-Release Tablets should be administered with food.

Common Side effects of Danavish Glimepiride+Metformin 2mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Danavish Glimepiride+Metformin 2mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Danavish Glimepiride+Metformin 2mg/500mg SR Tablets. Ingest the tablets whole; do not chew, crush, or divide them. Administer this medication with a meal.

How Danavish Glimepiride+Metformin 2mg/500mg Tablet SR works:

Danavish Glimepiride/Metformin 2mg/500mg Extended-Release Tablets combine glimepiride and metformin, two distinct anti-diabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Danavish Glimepiride+Metformin 2mg/500mg SR tablets is dangerous.

PregnancyPregnancyCONSULT YOUR DOCTOR

The combined medication Danavish Glimepiride+Metformin 2mg/500mg SR tablets may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Patient consultation with their doctor is advised.

Breast feedingBreast feedingUNSAFE

Lactation and Danavish Glimepiride+Metformin 2mg/500mg SR tablets are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Danavish Glimepiride+Metformin 2mg/500mg SR tablets, as dose modification may be necessary. Individuals with severe kidney disease should avoid this medication. Consistent monitoring of renal function is recommended during treatment. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use Danavish Glimepiride+Metformin 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Individuals with mild to moderate liver disease should begin with a low dose; however, use is contraindicated in those with severe liver disease. Medical advice is essential.

What if you forget to take Danavish Glimepiride+Metformin 2mg/500mg Tablet SR :

Should you forget to take a Danavish Glimepiride+Metformin 2mg/500mg Tablet SR, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Danavish Glimepiride+Metformin 2mg/500mg Tablet SR

LabelValue
Developing Habits No.
Type of Therapy Diabetes medication

FAQs on Danavish Glimepiride+Metformin 2mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Danavish Glimepiride+Metformin 2mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency resulting from excess blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). While rare, this risk is heightened in patients with kidney disease, older adults, and those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Danavish Glimepiride+Metformin and seek immediate medical attention.
Danavish Glimepiride/Metformin 2mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Danavish Glimepiride+Metformin 2mg/500mg SR tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Danavish Glimepiride+Metformin 2mg/500mg SR tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Danavish Glimepiride+Metformin 2mg/500mg SR Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Danavish Glimepiride+Metformin 2mg/500mg SR tablets with alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Danavish Glimepiride+Metf...
20
MRP 23
13% off